title: Left atrial deformation and nonischemic dilated cardiomyopathy. A 2D speckle-tracking imaging study.
abstract: BACKGROUND
  Left ventricular filling pressure (LVFP) is raised by the compromised contraction and impaired ventricular compliance in dilated hearts with systolic dysfunction. Timely recognition and staging of this condition are important for planning of the treatment strategy and making the prognosis. Two-dimensional speckle- tracking echocardiography (2D-STE) has recently enabled the quantification of left atrial (LA) myocardial deformation dynamics. In this study, echocardiographic indicators of increased LVFP and NT-pro-BNP were compared with LA strain measured by 2D-STE.
  
  
  METHODS
  A total of 49 nonischemic dilated cardiomyopathy (DCMP) patients were included in the study. All patients underwent standard 2D echocardiography. In the 2D-STE analysis of the LA, global longitudinal LA strain during ventricular systole (GLAs-res) and strain during late diastole (GLAs-pump) were obtained. NT-pro-BNP levels were measured. The patients were divided into two groups--normal (group 1) and increased (group 2) LVFP--according to E/A ratio, E velocity, and E/E' ratio.
  
  
  RESULTS
  LAVi-max, LAVi-min, and NT-pro-BNP were higher in group 2, whereas LAtotalEF, LAactiveEF, GLAs-res, and GLAs-pump were lower. In univariate analysis, a good negative correlation was seen between GLAs-res vs. NT-pro-BNP, GLAs-res vs. LAVi-max, and GLAs-res vs. E/E' ratio; a good negative correlation was present between GLAs-pump vs. NT-pro-BNP, GLAs-pump vs. LAVi-max, and GLAs-pump vs. E/E' ratio. LAVi-max, LAactiveEF, NT-pro-BNP, GLas-res, and GLAs-pump were studied by logistic regression analysis. GLAs-res (p = 0.009, OR = 0.593, 95 % CI 0.4-0.877), NT-pro-BNP (p = 0.028, OR = 1.027, 95 % CI 1.003-1.052), and LAactiveEF (p = 0.022, OR = 0.001, 95 % CI 0.001-0.024) were found to be independent predictors of increased LVFP.
  
  
  CONCLUSIONS
  2D-STE-based LA function is impaired in patients with nonischemic DCMP. LA reservoir and pump function parameters together with NT-pro-BNP levels might be useful in estimating LVFP in this patient group.
authors: Cardiology Clinic, Kosuyolu Heart, Education & Research Hospital, 34846, Kartal, Istanbul, Turkey, ahmetguler01@yahoo.com.tr.
authors: A
authors: A
authors: Guler
authors: K M
authors: KM
authors: Tigen
authors: C
authors: C
authors: Dundar
authors: T
authors: T
authors: Karaahmet
authors: C Y
authors: CY
authors: Karabay
authors: S M
authors: SM
authors: Aung
authors: T
authors: T
authors: Akgun
authors: M
authors: M
authors: Bulut
authors: C
authors: C
authors: Kirma
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000000981:diagnostic imaging* / Q000503:physiopathology*; D004452:Echocardiography / Q000379:methods; D055119:Elastic Modulus; D054459:Elasticity Imaging Techniques / Q000379:methods*; D005260:Female; D006325:Heart Atria / Q000000981:diagnostic imaging* / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications / Q000000981:diagnostic imaging / Q000503:physiopathology; D020097:Natriuretic Peptide, Brain / Q000097:blood; D015588:Observer Variation; D010446:Peptide Fragments / Q000097:blood; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013318:Stroke Volume; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging* / Q000209:etiology / Q000503:physiopathology*; D020257:Ventricular Remodeling / Q000502:physiology
chemical_list: D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain
references: Int J Cardiol. 2009 Mar 6;132(3):354-63
references: 18255178
references: Cardiol J. 2010;17(3):274-80
references: 20535718
references: Eur Heart J Cardiovasc Imaging. 2012 Jun;13(6):524-30
references: 22166592
references: Circulation. 1994 Dec;90(6):2772-9
references: 7994820
references: Am J Cardiol. 1990 Apr 1;65(13):903-8
references: 2138849
references: Circulation. 2009 Jan 6;119(1):62-70
references: 19075104
references: Am Heart J. 1994 Aug;128(2):308-15
references: 8037098
references: Eur Heart J. 2007 Oct;28(20):2539-50
references: 17428822
references: Heart Fail Rev. 2007 Jun;12(2):131-42
references: 17440808
references: J Am Coll Cardiol. 2004 Feb 4;43(3):360-7
references: 15013115
references: Circulation. 2002 Jul 23;106(4):416-22
references: 12135939
references: Eur J Echocardiogr. 2006 Mar;7(2):79-108
references: 16458610
references: Am J Cardiol. 2005 Apr 1;95(7):892-5
references: 15781027
references: Am Heart J. 1991 Mar;121(3 Pt 1):864-71
references: 2000754
references: J Am Soc Echocardiogr. 2009 Feb;22(2):107-33
references: 19187853
references: Am J Cardiol. 1988 Jan 1;61(1):136-41
references: 3337002
references: Cleve Clin J Med. 2006 Feb;73(2):149-52, 155-7
references: 16478039
references: Circulation. 2004 Mar 2;109(8):972-7
references: 14967722
references: J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
references: 20620859
references: J Am Coll Cardiol. 1995 Apr;25(5):1162-9
references: 7897130
references: J Am Coll Cardiol. 1995 Nov 15;26(6):1417-23
references: 7594064